People with HIV-AIDS who are treated promptly and properly have the same life expectancy as the uninfected, even in the poorest parts of Africa, new Canadian research shows.
The study, published in Tuesday’s edition of the Annals of Internal Medicine, shows that patients in Uganda being treated with antiretroviral therapy at age 20 can expect to live, on average, to age 56.7. Average life expectancy in Uganda, where the study was conducted, is 55.
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below
